製品情報

プロテインSキット

1. 鈴木宏治他.凝固制御因子プロテインSの構造と機能. 臨床検査 2011; 55: 340-346.
2. 濱﨑直孝他.深部静脈血栓症とプロテインS異常症. 臨床検査 2011; 55: 357-365.
3. 林辰弥他. Protein S-Tokushima(K155E). 臨床検査 2011; 55: 373-377.
4. Tsuda T et al. New quantitative total protein S-assay system for diagnosing protein S type II deficiency：
   clinical application of the screening system for protein S type II deficiency. Blood Coagul Fibrinolysis
   2012; 23: 56-63.
5. 宮田敏行. 先天性血栓性素因の遺伝子解析. 臨床検査 2009; 53: 1123-1128.
6. 津田博子他. アジア人特有の血栓性素因：プロテインS 異常症.日本血栓止血学会誌 2012; 23: 379-382.
7. Hamasaki N et al. Activated protein C anticoagulant system dysfunction and thrombophilia in Asia.
   Ann Lab Med 2013; 33: 8-13.
8. Noguchi K et al. Plasma phenotypes of protein S Lys196Glu and protein C Lys193del variants prevalent
   among young Japanese women. Blood Coagul Fibrinolysis 2019; 30: 393-400.
9. 月森清巳. 妊娠とプロテインS. 臨床検査 2011; 55: 378-384.
10. Takeuchi S et al. Evaluation of the plasma protein S dynamics during pregnancy using a total protein S
    assay: Protein S-specific activity decreased from the second trimester. J Obstet Gynaecol Res 2020; 46:376-381.
11. Kuma H et al. Protein S-specific activity assay system is not affected by direct oral anticoagulants.
    Thromb Res 2018; 168: 60-62.